You are viewing the site in preview mode

Skip to main content

Advertisement

Table 4 Odds ratio [95 % CI] for medication use over time

From: Implementing shared decision making in federally qualified health centers, a quasi-experimental design study: the Office-Guidelines Applied to Practice (Office-GAP) program

  (1) (2) (3) (4) (5)
  Aspirin/Plavix Statin ACEI/ABR Beta-blocker “Global” medication adherence
3 months 1.50* 1.12* 1.21 1.31 1.19
  [1.05, 2.15] [1.00, 1.25] [0.84, 1.75] [0.91, 1.89] [0.85, 1.66]
6 months 1.92** 1.34 1.38 1.75* 1.52*
  [1.27, 2.92] [0.99, 1.81] [0.92, 2.09] [1.07, 2.85] [1.01, 2.29]
12 months 1.81** 1.52* 1.13 1.75* 1.34
  [1.17, 2.79] [1.07, 2.16] [0.72, 1.78] [1.07, 2.85] [0.87, 2.06]
Age 1.02 0.99 1.03 0.99 1.03
  [0.98, 1.06] [0.94, 1.04] [0.98, 1.08] [0.93, 1.06] [0.99, 1.08]
Black 0.90 1.16 0.90 0.43 0.87
  [0.36, 2.22] [0.43, 3.08] [0.36, 2.28] [0.10, 1.84] [0.35, 2.13]
Female 1.27 2.06 0.77 0.77 0.72
  [0.54, 2.97] [0.83, 5.07] [0.31, 1.89] [0.19, 3.10] [0.30, 1.70]
Medicaid 0.35 2.75 0.56 0.36 0.46
  [0.11, 1.07] [0.80, 9.38] [0.17, 1.81] [0.07, 1.95] [0.15, 1.38]
Medicare 0.96 2.16 0.71 0.70 0.74
  [0.34, 2.72] [0.73, 6.40] [0.24, 2.05] [0.11, 4.68] [0.26, 2.10]
Charlson index 1.16 1.03 0.83 1.09 0.83
  [0.85, 1.59] [0.74, 1.42] [0.61, 1.13] [0.70, 1.71] [0.61,1.12]
N obs. 300 316 296 132 332
  1. OR with 95 % confidence intervals in brackets
  2. Reference groups are: Pre-GAP; male; white or other race; other insurance or uninsured, Age and Charlson index centered at their respective means (53.5 and 2.7)
  3. *p < 0.05, **p < 0.01